Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
99.4 SEK | +0.61% | -4.42% | +26.46% |
Apr. 25 | Devyser Receives IVDR Approval for Post-Transplant Monitoring Software | CI |
Mar. 11 | Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.46% | 147M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- DVYSR Stock
- News Devyser Diagnostics AB
- Sweden’s Devyser Wins SEK1.5 Million Tender in Italy for Cystic Fibrosis Test Kits